The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II/III trial of active immunotherapy with OPT-822/OPT-821 in patients with metastatic breast cancer.
 
Chiun-Sheng Huang
Honoraria - Novartis; Roche
Consulting or Advisory Role - Roche
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Roche (Inst)
 
Alice L Yu
Leadership - OPKO Health
Stock and Other Ownership Interests - Merck; OBI Pharma; OPKO Health
Honoraria - United Therapeutics
Consulting or Advisory Role - OBI Pharma; United Therapeutics
Speakers' Bureau - United Therapeutics
Research Funding - OBI Pharma
Patents, Royalties, Other Intellectual Property - OBI Pharma
 
Ling-Ming Tseng
No Relationships to Disclose
 
Louis W. C. Chow
No Relationships to Disclose
 
Ming-Feng Hou
No Relationships to Disclose
 
Sara A. Hurvitz
Honoraria - Genentech/Roche
Research Funding - Amgen (Inst); Bayer (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Dignitana (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merrimack (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Puma Biotechnology (Inst); sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Genentech/Roche; Lilly; Lilly; Novartis; Pfizer
 
Richard B. Schwab
Stock and Other Ownership Interests - Samumed (I)
Patents, Royalties, Other Intellectual Property - Regents of the University of California
 
Chi-Huey Wong
No Relationships to Disclose
 
James L. Murray
Honoraria - OBI Pharma
Consulting or Advisory Role - OBI Pharma
Research Funding - OBI Pharma
Travel, Accommodations, Expenses - OBI Pharma
 
Hsien-Kun Chang
Research Funding - OBI Pharma (Inst); Roche (Inst)
 
Hong-Tai Chang
No Relationships to Disclose
 
Shin-Cheh Chen
No Relationships to Disclose
 
Sung-Bae Kim
No Relationships to Disclose
 
Youe-Kong Shue
Employment - OBI Pharma
Leadership - OBI Pharma
Stock and Other Ownership Interests - OBI Pharma
Travel, Accommodations, Expenses - OBI Pharma
 
Hope S. Rugo
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health
Research Funding - Celsion (Inst); Celsion (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Nektar; Novartis; OBI Pharma; Roche/Genentech